Xap Therapeutics

Developer of cell therapies to treat cancer and autoimmune diseases

placeCambridge, England, United Kingdom calendar_todayFounded 2019 groups12 employees language xaptherapeutics.com

Registered entities

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital233%
Other / undisclosed467%
Coming soon